Categories: Tech

Rackspace Technology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

 | Source: Rackspace US, Inc.

SAN ANTONIO, Sept. 05, 2025 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a global provider of hybrid cloud and AI solutions, today announced that on September 4, 2025, the Company granted inducement equity awards to Gajen Kandiah in connection with his appointment as the Company’s new Chief Executive Officer.

Mr. Kandiah received 4,000,000 restricted stock units (RSUs) and non-qualified stock options to purchase 6,000,000 shares of the Company’s common stock. The stock options have an exercise price of $1.30 per share, which is equal to the closing price of the Company’s common stock on the grant date, and a maximum ten-year term. The RSUs and stock options vest in equal annual installments on each of September 3, 2026, 2027, 2028 and 2029, generally subject to Mr. Kandiah’s continued employment through the respective vesting dates.

In accordance with Nasdaq Listing Rule 5635(c)(4), the equity awards were an inducement material to Mr. Kandiah’s entering into employment with the Company. The awards were approved by a majority of the independent members of the Company’s board of directors outside of the Company’s shareholder-approved equity incentive plan.

About Rackspace Technology

Rackspace Technology is a leading provider of end-to-end hybrid multicloud technology services and AI solutions company. We design, build, and operate our customers’ cloud environments across all major technology platforms, irrespective of technology stack or deployment model. We partner with our customers at every stage of their cloud journey, enabling them to modernize applications, build new products, and adopt innovative technologies.

IR Contact
Sagar Hebbar
ir@rackspace.com

PR Contact
Cheryl Amerine
publicrelations@rackspace.com

GlobeNews Wire

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

3 days ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

1 week ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago